Surgical therapy of multidrug-resistant pulmonary tuberculosis in Peru: report of 304 cases

Authors

  • Jose G. Somocurcio Servicio de Cirugía de Tórax y Cardiovascular, Hospital Nacional Hipólito Unanue. Lima, Perú. Facultad de Medicina, universidad Nacional Mayor de San Marcos. Lima, Perú. Médico.
  • Alfredo Sotomayor Servicio de Cirugía de Tórax y Cardiovascular, Hospital Nacional Hipólito Unanue. Lima, Perú. Médico, Cirujano de Tórax y Cardiovascular.
  • Sonya Shin Socios en Salud. Lima, Perú. Division of Global Health Equity, Brigham and Women´s Hospital. Massachusetts, USA. Médico, Magíster en Salud Pública.
  • María Valcárcel Servicio de Cirugía de Tórax y Cardiovascular, Hospital Nacional Hipólito unanue. Lima, Perú. Facultad de Medicina, universidad Nacional Mayor de San Marcos. Lima, Perú. Médica, Cirujana General.
  • Silvia Portilla Servicio de Cirugía de Tórax y Cardiovascular, Hospital Nacional Hipólito Unanue. Lima, Perú. Médica anestesióloga.
  • Dalia Guerra Socios en Salud. Lima, Perú. Enfermera.
  • Jennifer Furin Socios en Salud. Lima, Perú. Division of Global Health Equity, Brigham and Women´s Hospital. Massachusetts, USA. Médica, PhD en Antropología.
  • Jaime Bayona Facultad de Medicina, Universidad Nacional Mayor de San Marcos. Lima, Perú. Médico infectólogo.

DOI:

https://doi.org/10.17843/rpmesp.2009.263.1377

Keywords:

Multidrug-resistant tuberculosis, Thoracic surgery, Pneumonectomy, Pulmonary tuberculosis, Peru

Abstract

Treatment for pulmonary tuberculosis (TB) is drug-based but the emergence of drug-resistance has decreased its therapeutic efficacy. Pulmonary surgery is an important beneficial adjuvant strategy for MDR TB treatment in this context. Objectives. To describe the clinical characteristics results and complications in a series of 304 patients with MDR TB submitted to surgical therapy. Material and methods. Between May of 1999 and January of 2007 a total of 336 surgical interventions were performed on 304 patients from the National Program of TB Control who, were operated by a surgical team of the Ministry of Health in the Hipolito unanue National Hospital and in a Private Center in Lima. Results. Most cases were male (60%) and the mean age was 28 years. Patients were resistant to a median of 5 drugs. Cavitary lesions were the most common (91.8%) and lobectomy was the most commonly performed surgical procedure (68.4%). Postoperative morbidity and mortality occurred in 12.8% and 2% respectively. Patients were followed post-operatively for a maximum time of 79.3 months and healing was reached in the 77.2% of cases. Conclusions. Pulmonary adjuvant surgery on MDR TB patients is an effective alternative for cure. This strategy should be included as part of treatment programs for MDR TB.

Downloads

Download data is not yet available.

Downloads

Published

2009-09-30

Issue

Section

Research Articles

How to Cite

1.
Somocurcio JG, Sotomayor A, Shin S, Valcárcel M, Portilla S, Guerra D, et al. Surgical therapy of multidrug-resistant pulmonary tuberculosis in Peru: report of 304 cases. Rev Peru Med Exp Salud Publica [Internet]. 2009 Sep. 30 [cited 2024 Jul. 14];26(3). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/1377

Most read articles by the same author(s)